SPTBN4

Chr 19AR

spectrin beta, non-erythrocytic 4

Also known as: CMND, NEDHND, QV, SPNB4, SPTBN3

Spectrin is an actin crosslinking and molecular scaffold protein that links the plasma membrane to the actin cytoskeleton, and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. It is composed of two antiparallel dimers of alpha- and beta- subunits. This gene is one member of a family of beta-spectrin genes. The encoded protein localizes to the nuclear matrix, PML nuclear bodies, and cytoplasmic vesicles. A highly similar gene in the mouse is required for localization of specific membrane proteins in polarized regions of neurons. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.191 OMIM phenotype
Clinical SummarySPTBN4
🧬
Gene-Disease Validity (ClinGen)
neurodevelopmental disorder with hypotonia, neuropathy, and deafness · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
34 unique Pathogenic / Likely Pathogenic· 426 VUS of 648 total submissions
📖
GeneReview available — SPTBN4
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.19LOEUF
pLI 1.000
Z-score 8.48
OE 0.12 (0.080.19)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.93Z-score
OE missense 0.70 (0.660.74)
958 obs / 1367.4 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.12 (0.080.19)
00.351.4
Missense OE?0.70 (0.660.74)
00.61.4
Synonymous OE?0.85
01.21.6
LoF obs/exp: 13 / 108.1Missense obs/exp: 958 / 1367.4Syn Z: 2.79
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSPTBN4-related neurodevelopmental disorder with hypotonia, neuropathy, and deafnessLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.5279th %ile
GOF
0.75top 25%
LOF
0.51top 25%

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

648 submitted variants in ClinVar

Classification Summary

Pathogenic16
Likely Pathogenic18
VUS426
Likely Benign104
Benign55
Conflicting9
16
Pathogenic
18
Likely Pathogenic
426
VUS
104
Likely Benign
55
Benign
9
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
15
1
0
0
16
Likely Pathogenic
17
1
0
0
18
VUS
3
420
3
0
426
Likely Benign
0
16
10
78
104
Benign
0
7
39
9
55
Conflicting
9
Total354455287628

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

10 pathogenic / likely-pathogenic (of 12) ClinVar copy-number / structural variants overlap SPTBN4 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SPTBN4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →